StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
11
Publishing Date
2021 - 09 - 09
11
Sector
Consumer non-durables
2
Consumer services
1
Electronic technology
1
Finance
2
Health technology
2
Manufacturing
1
Producer manufacturing
1
Technology services
2
Tags
Awards
1
Biotech-beach
1
Cancer
2
Clinical-trials-phase-i
1
Collaboration
1
Growth
1
Hotel
1
Immunotherapy
1
N/a
9
Nivolumab
1
Phase 1
1
Phase 1b
1
Phase 2b
1
Presentation
1
Prostate cancer
1
Risk
1
Sabizabulin
1
Therapy
1
Travel
1
Trial
1
Entities
Angi homeservices inc.
1
Arrival
1
Bank7 corp.
1
Bristol-myers squibb company
1
Campbell soup company
1
Gilead sciences, inc.
1
Huntington ingalls industries, inc.
1
Kellogg company
1
Lear corporation
1
Lendingclub corporation
1
Open text corporation
1
Royal caribbean group
1
Veru inc.
1
Symbols
ANGI
1
ARVL
1
BMY
1
BSVN
1
CPB
1
GILD
1
HII
1
K
1
LC
1
LEA
1
OTEX
1
RCL
1
VERU
1
Exchanges
Nasdaq
5
Nyse
7
Crawled Date
2021 - 11 - 12
31
2021 - 11 - 09
24
2021 - 11 - 08
71
2021 - 11 - 01
36
2021 - 10 - 29
26
2021 - 10 - 26
43
2021 - 10 - 21
24
2021 - 10 - 18
20
2021 - 10 - 13
26
2021 - 10 - 12
31
2021 - 10 - 07
55
2021 - 10 - 06
47
2021 - 10 - 05
20
2021 - 10 - 04
32
2021 - 09 - 27
39
2021 - 09 - 23
23
2021 - 09 - 20
43
2021 - 09 - 15
26
2021 - 09 - 02
24
2021 - 08 - 24
22
2021 - 08 - 19
20
2021 - 08 - 18
43
2021 - 08 - 12
34
2021 - 08 - 06
24
2021 - 08 - 05
33
2021 - 08 - 03
29
2021 - 07 - 29
25
2021 - 07 - 22
28
2021 - 07 - 21
25
2021 - 07 - 20
30
2021 - 07 - 19
21
2021 - 07 - 15
35
2021 - 07 - 13
20
2021 - 07 - 12
24
2021 - 07 - 07
27
2021 - 06 - 24
24
2021 - 06 - 22
20
2021 - 06 - 16
24
2021 - 06 - 14
21
2021 - 06 - 09
27
2021 - 06 - 04
20
2021 - 06 - 02
25
2021 - 06 - 01
27
2021 - 05 - 26
24
2021 - 05 - 25
25
2021 - 05 - 24
29
2021 - 05 - 20
24
2021 - 05 - 19
27
2021 - 05 - 17
30
2021 - 05 - 13
32
2021 - 05 - 06
24
2021 - 05 - 05
34
2021 - 04 - 28
23
2021 - 04 - 26
42
2021 - 04 - 22
35
2021 - 04 - 16
21
2021 - 04 - 14
23
2021 - 04 - 13
23
2021 - 04 - 08
20
2021 - 04 - 07
25
Crawled Time
00:00
16
01:00
5
02:00
4
03:00
3
04:00
3
05:00
2
06:00
2
07:00
6
08:00
5
09:00
6
10:00
6
11:00
31
12:00
76
12:15
14
13:00
38
13:15
11
14:00
25
14:15
10
15:00
22
15:15
13
16:00
16
17:00
21
18:00
17
19:00
24
20:00
19
21:00
43
22:00
28
23:00
10
Source
www.biospace.com
2
www.prnewswire.com
9
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
crawled date :
2021 - 09 - 09
crawled time :
13:15
save search
CG Oncology Announces Clinical Trial Collaboration with Bristol Myers Squibb to Evaluate Oncolytic Immunotherapy CG0070 in Combination with OPDIVO® (nivolumab) in Metastatic Urothelial Cancer
Published:
2021-09-09
(Crawled : 13:15)
- biospace.com/
BMY
|
$48.04
-0.46%
5.8M
|
Health Technology
|
-25.66%
|
O:
-0.74%
H:
0.49%
C:
-1.33%
immunotherapy
therapy
collaboration
cancer
trial
nivolumab
LendingClub Expands Investor Access to Personal Loans via LCX Link
Published:
2021-09-09
(Crawled : 13:15)
- prnewswire.com
LC
4
|
$7.645
-0.46%
540K
|
Finance
|
-74.77%
|
O:
0.13%
H:
1.9%
C:
0.07%
St Kitts and Nevis is Reopening Travel and Welcoming Major Cruise Ships Back to its Shores
Published:
2021-09-09
(Crawled : 13:15)
- prnewswire.com
RCL
|
$127.38
0.62%
1.3M
|
Consumer Services
|
57.68%
|
O:
-0.17%
H:
3.48%
C:
1.87%
travel
ACG Announces 2021 Corporate Growth Award Winners
Published:
2021-09-09
(Crawled : 13:15)
- prnewswire.com
HII
|
$272.48
-0.56%
120K
|
Electronic Technology
|
37.35%
|
O:
-0.05%
H:
0.87%
C:
-0.04%
growth
awards
The Risks and Rewards of DIY: Is It Worth It?
Published:
2021-09-09
(Crawled : 13:15)
- prnewswire.com
ANGI
A
|
$2.03
1.0%
490K
|
Technology Services
|
-80.24%
|
O:
0.29%
H:
2.35%
C:
1.57%
risk
Omni Boston Hotel At The Seaport Opens Its Doors
Published:
2021-09-09
(Crawled : 13:15)
- prnewswire.com
ARVL
|
$0.49
0.37%
2.5M
|
Manufacturing
|
-95.45%
|
O:
-0.83%
H:
3.92%
C:
3.67%
hotel
Campbell's® Chunky® Debuts New Creative Campaign: Lunchtime Is Your Halftime
Published:
2021-09-09
(Crawled : 13:15)
- prnewswire.com
CPB
4
|
$43.085
0.17%
640K
|
Consumer Non-Durables
|
-0.02%
|
O:
0.07%
H:
0.27%
C:
-0.58%
MorningStar Farms® Creates Plant-Based Playbook for Football Season Snacking, Taps Tahj Mowry to QB 'MVP' Effort
Published:
2021-09-09
(Crawled : 13:15)
- prnewswire.com
K
S
|
$55.95
0.79%
850K
|
Consumer Non-Durables
|
-11.96%
|
O:
-0.08%
H:
0.44%
C:
0.0%
Bank7 Corp. Declares Quarterly Cash Dividend on Common Stock
Published:
2021-09-09
(Crawled : 13:15)
- prnewswire.com
BSVN
|
$27.72
0.4%
180
|
Finance
|
29.02%
|
O:
-0.05%
H:
2.06%
C:
-3.69%
OpenText Launches Virtual Summit for Business Leaders to Share Best Practices on Digitizing Supply Chains to Minimize Disruption
Published:
2021-09-09
(Crawled : 13:15)
- prnewswire.com
LEA
|
$131.6
-0.3%
120K
|
Producer Manufacturing
|
-15.98%
|
O:
0.01%
H:
0.41%
C:
-0.27%
OTEX
|
$34.5
0.09%
130K
|
Technology Services
|
-34.57%
|
O:
-0.35%
H:
0.54%
C:
-0.9%
Veru Announces Oral Presentation of Updated Data from the Phase 1b/2 Sabizabulin Study in Men with Metastatic Castration Resistant Prostate Cancer at the 2021 ESMO Congress
Published:
2021-09-09
(Crawled : 13:15)
- biospace.com/
VERU
|
$1.23
-1.99%
1.8M
|
Health Technology
|
-86.48%
|
O:
-1.31%
H:
5.75%
C:
3.73%
GILD
|
$67.18
-0.19%
2.5M
|
Health Technology
|
-6.36%
|
O:
-0.33%
H:
0.06%
C:
-1.44%
presentation
prostate cancer
phase 1
cancer
phase 1b
sabizabulin
phase 2b
Gainers vs Losers
63%
37%
Top 10 Gainers
INVO
|
$2.78
265.79%
200M
|
Health Technology
EDBL
|
$7.4
62.64%
12M
|
RYDE
|
$3.89
42.49%
1.2M
|
n/a
GRTX
|
$0.237
39.41%
13M
|
Health Technology
VNDA
|
$5.28
30.37%
21M
|
Health Technology
VIRX
|
$0.912
27.59%
170K
|
Manufacturing
WISA
4
|
$7.72
26.56%
51M
|
Electronic Technology
LUXH
|
$1.045
26.06%
540K
|
RCAT
|
$1.41
25.89%
3.2M
|
Information
TCON
|
$2.135
24.85%
440K
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.